The National Institute for Bioprocessing Research and Training (NIBRT), an Irish-based center of excellence in biopharmaceutical manufacturing; Firefinch Software, a United Kingdom-based software consultancy; and eg technology, a product design, engineering, and development specialist with offices in the UK and Ireland, are joining EIT Health Ireland–UK, a co-location center of EIT Health, which is a part of the European Union’s European Institute of Innovation and Technology (1).
EIT Health is a 100-member strong network of organizations in various fields—business, education, government, research, and health services delivery—that work together to address healthcare challenges across Europe with collective technological knowledge and innovation (1).
A pan-European innovation network
Key Takeaways
- NIBRT, Firefinch Software, and eg technology have joined EIT Health Ireland–UK to foster collaboration in healthcare innovation across Europe.
- Membership provides access to a pan-European innovation network, supporting bioprocessing training, product development, and accelerated tech adoption.
- The partnership highlights a trend of increased collaboration among European pharma and tech sectors, despite ongoing geopolitical uncertainties.
“We are delighted to welcome NIBRT, Firefinch, and eg technology to the EIT Health Ireland-UK network,” said Graham Armitage, managing director at EIT Health Ireland–UK, in a press release (1). “Each brings a unique strength to our network. From world-class bioprocessing training and market-ready product design to expert solutions that can accelerate innovation adoption, their expertise enhances our collaborative mission to create meaningful, scalable healthcare solutions for Europe.”
By joining the network, NIBRT, Firefinch, and eg technology gain access to what EIT Health referred to as a pan-European innovation base. Opportunities will be available to the three new network members to contribute to the EIT Health Think Tank and other EU-supported initiatives.
“At NIBRT, we are committed to advancing excellence in bioprocessing through training and research that meets the evolving needs of the biopharma sector,” Fiona Killard-Lynch, chief scientific officer and director of Research and Innovation at NIBRT, said in the release (1). “Being part of this vibrant European network opens up exciting opportunities to work with like-minded partners and bring meaningful, scalable health solutions to patients across Europe.”